Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $0.65 M | -89.93% |
2023 | $6.48 M | -41.81% |
2022 | $11.14 M | -31.9% |
2021 | $16.36 M | -20.71% |
2020 | $20.64 M | 303.63% |
2019 | $5.11 M | -70.5% |
2018 | $17.33 M | 8.82% |
2017 | $15.92 M | -17.35% |
2016 | $19.27 M | -75.68% |
2015 | $79.23 M | 19.37% |
2014 | $66.37 M | 258.49% |
2013 | $18.51 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.14 B | $0.60 B | ๐บ๐ธ USA |
Pfizer PFE | $31.87 M | $0.32 B | ๐บ๐ธ USA |
Amgen AMGN | $65.7 M | $0.18 B | ๐บ๐ธ USA |
Sanofi SNY | $26.25 M | $54.4 M | ๐ซ๐ท France |
Merck MRK | $8.48 M | $0.18 B | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $15.53 M | $26.02 M | ๐ฌ๐ง UK |
Curis CRIS | N/A | $1.02 M | ๐บ๐ธ USA |
AVEO Oncology
AVEO | N/A | $0.04 M | ๐บ๐ธ USA |